Logo image of CELU

CELULARITY INC-A (CELU) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CELU - US1511902041 - Common Stock

1.34 USD
-0.01 (-0.74%)
Last: 12/17/2025, 9:41:47 AM
1.69 USD
+0.35 (+26.12%)
After Hours: 12/10/2025, 8:00:00 PM
Fundamental Rating

1

Overall CELU gets a fundamental rating of 1 out of 10. We evaluated CELU against 529 industry peers in the Biotechnology industry. CELU has a bad profitability rating. Also its financial health evaluation is rather negative. CELU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CELU had negative earnings in the past year.
In the past year CELU has reported a negative cash flow from operations.
In the past 5 years CELU reported 4 times negative net income.
CELU had a negative operating cash flow in each of the past 5 years.
CELU Yearly Net Income VS EBIT VS OCF VS FCFCELU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -70.65%, CELU is not doing good in the industry: 62.76% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -70.65%
ROE N/A
ROIC N/A
ROA(3y)-58.77%
ROA(5y)-40.28%
ROE(3y)-375.51%
ROE(5y)-245.63%
ROIC(3y)N/A
ROIC(5y)N/A
CELU Yearly ROA, ROE, ROICCELU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

CELU has a better Gross Margin (50.61%) than 75.61% of its industry peers.
In the last couple of years the Gross Margin of CELU has grown nicely.
CELU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.74%
GM growth 5YN/A
CELU Yearly Profit, Operating, Gross MarginsCELU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

CELU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CELU has more shares outstanding
The number of shares outstanding for CELU has been increased compared to 5 years ago.
CELU has a worse debt/assets ratio than last year.
CELU Yearly Shares OutstandingCELU Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CELU Yearly Total Debt VS Total AssetsCELU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

CELU has an Altman-Z score of -13.30. This is a bad value and indicates that CELU is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -13.30, CELU is not doing good in the industry: 78.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.3
ROIC/WACCN/A
WACC6.08%
CELU Yearly LT Debt VS Equity VS FCFCELU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

CELU has a Current Ratio of 0.16. This is a bad value and indicates that CELU is not financially healthy enough and could expect problems in meeting its short term obligations.
CELU's Current ratio of 0.16 is on the low side compared to the rest of the industry. CELU is outperformed by 96.03% of its industry peers.
A Quick Ratio of 0.12 indicates that CELU may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.12, CELU is doing worse than 96.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.12
CELU Yearly Current Assets VS Current LiabilitesCELU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

CELU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -119.42%.
The Revenue for CELU has decreased by -15.81% in the past year. This is quite bad
CELU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.47% yearly.
EPS 1Y (TTM)-119.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.97%
Revenue 1Y (TTM)-15.81%
Revenue growth 3Y36.47%
Revenue growth 5YN/A
Sales Q2Q%-43.16%

3.2 Future

CELU is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -119.65% yearly.
Based on estimates for the next years, CELU will show a very strong growth in Revenue. The Revenue will grow by 98.27% on average per year.
EPS Next Y-752.63%
EPS Next 2Y-119.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year27.37%
Revenue Next 2Y49.72%
Revenue Next 3Y144.15%
Revenue Next 5Y98.27%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CELU Yearly Revenue VS EstimatesCELU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CELU Yearly EPS VS EstimatesCELU Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CELU. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CELU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CELU Price Earnings VS Forward Price EarningsCELU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CELU Per share dataCELU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

CELU's earnings are expected to decrease with -119.65% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-119.65%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CELU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CELULARITY INC-A

NASDAQ:CELU (12/17/2025, 9:41:47 AM)

After market: 1.69 +0.35 (+26.12%)

1.34

-0.01 (-0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-17 2025-11-17/dmh
Earnings (Next)05-07 2026-05-07/amc
Inst Owners13.41%
Inst Owner Change16.69%
Ins Owners12.96%
Ins Owner Change1.61%
Market Cap37.96M
Revenue(TTM)40.58M
Net Income(TTM)-80.71M
Analysts82.86
Price Target6.12 (356.72%)
Short Float %2.97%
Short Ratio4.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.58%
Min EPS beat(2)-33.33%
Max EPS beat(2)42.48%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-1057.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.94
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.34
EYN/A
EPS(NY)-2.8
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.43
BVpS-0.71
TBVpS-1.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.61%
FCFM N/A
ROA(3y)-58.77%
ROA(5y)-40.28%
ROE(3y)-375.51%
ROE(5y)-245.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.74%
GM growth 5YN/A
F-Score1
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.12
Altman-Z -13.3
F-Score1
WACC6.08%
ROIC/WACCN/A
Cap/Depr(3y)39.96%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.97%
EPS Next Y-752.63%
EPS Next 2Y-119.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.81%
Revenue growth 3Y36.47%
Revenue growth 5YN/A
Sales Q2Q%-43.16%
Revenue Next Year27.37%
Revenue Next 2Y49.72%
Revenue Next 3Y144.15%
Revenue Next 5Y98.27%
EBIT growth 1Y-21.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y88.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.75%
OCF growth 3YN/A
OCF growth 5YN/A

CELULARITY INC-A / CELU FAQ

What is the ChartMill fundamental rating of CELULARITY INC-A (CELU) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CELU.


Can you provide the valuation status for CELULARITY INC-A?

ChartMill assigns a valuation rating of 0 / 10 to CELULARITY INC-A (CELU). This can be considered as Overvalued.


How profitable is CELULARITY INC-A (CELU) stock?

CELULARITY INC-A (CELU) has a profitability rating of 1 / 10.


Can you provide the financial health for CELU stock?

The financial health rating of CELULARITY INC-A (CELU) is 0 / 10.


What is the expected EPS growth for CELULARITY INC-A (CELU) stock?

The Earnings per Share (EPS) of CELULARITY INC-A (CELU) is expected to decline by -752.63% in the next year.